Volume 24 (2021)
Volume 23 (2020)
Volume 22 (2019)
Volume 21 (2018)
Volume 20 (2017)
Volume 19 (2016)
Volume 18 (2015)
Volume 17 (2014)
Volume 16 (2013)
Volume 15 (2012)
Volume 14 (2011)
Volume 13 (2010)
Volume 12 (2009)
Volume 11 (2008)
Volume 10 (2007)
Volume 9 (2006)
Volume 8 (2005)
Volume 7 (2004)
Volume 6 (2002)
Volume 5 (2002)
Volume 4 (2000)
Volume 3 (1999)
Volume 2 (1998)
Volume 1 (1997)
1. Comparative evaluation of oral valacyclovir versus oral zinc sulfate in the treatment of cutaneous verruca: a hospitalbased, prospective clinical study

Ria Rai; Varsha Jamale

Volume 24, Issue 3 , September 2021, , Pages 179-185

http://dx.doi.org/10.22034/ijd.2021.136568

Abstract
  Background: Cutaneous verrucae (warts) are benign epithelial proliferations caused by human papillomavirus (HPV). HPV acts by upregulating epithelial cell replication and downregulating host immune responses. Hence, treatment could be aimed at the virus (via antiviral drugs like valacyclovir) or the ...  Read More

2. Clinical efficacy and tolerability of valacyclovir versus acyclovir in treatment of herpes zoster

Arun Achar; Pratim Chakraborty Partha; Tarapada Ghosh; Biswanath Naskar; Tapobrata Guharay; Samiran Bisai

Volume 14, Issue 2 , 2011, , Pages 52-57

Abstract
  Background: Acyclovir, a specific and selective inhibitor of replication of herpesviridae family, has well documented efficacy for speedy rash healing and decreasing pain of herpes zoster. Limited oral bioavailability of acyclovir requires frequent dosing. Valacyclovir is rapidly and almost completely ...  Read More